Table 3: Selected genetic causes of obesity Navigation Tips: First column and header row are frozen for easy reference Scroll horizontally and vertically to view all data Hover over rows to highlight them Use compact mode to fit more content Hover over truncated text to see full content Setmelanotide, an MC4R agonist and first-in-class treatment for hereditary obesity Setmelanotide, (Imcivree), is an MC4R agonist discovered by Ipsen SA and developed by Rhythm Pharmaceuticals that has been approved in the US since 2020 for treatment of obesity due to deficiencies of POMC, PCSK1 or LEPR confirmed by genetic testing 15 and since 2022 for syndromic obesity due to Bardet-Biedl Syndrome, a rare genetic ciliopathy 34
Glutathione and Niacinamide moisturizing cream, hypoallergenic formula, dermatologically tested
Supports Red Blood Cell Formation Low B12 levels can lead to anemia, making you feel weak and tired
Gut-focused patients often feel a calming effect sooner, within the first 2 to 4 weeks
Although your vials might have dark amber glass instead of clear glass protecting them, it is still necessary to protect the nutrients contained inside by shielding B-vitamins from all light